SUMANCT07053709
Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 7 words Show 5 more changesShow less
- Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Primary completion date changed from estimate of Nov 1, 2026 to Jun 1, 2026
- Study completion moved earlier from Nov 1, 2027 to Nov 1, 2026
- Study sites: 0 to 1
- Start date changed from estimate of Nov 1, 2026 to May 1, 2025
- Notable Start date: Nov 1, 2025 to Nov 1, 2026v3
- Notable Primary completion date: May 1, 2026 to Nov 1, 2026
- Start date: Jul 1, 2025 to Nov 1, 2025
- Study completion date: May 1, 2027 to Nov 1, 2027
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Search for hyperuricemia in every patient with MAFLD
Timeframe: At diagnosis and follow up after 6 month
Sites
1 site in 1 country
- Assiut UniversityAsyut, Egypt